Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter

As the field of ophthalmology continues to advance, a plethora of international congresses offer opportunities for professionals to explore the latest innovations, share insights, and foster collaborations. Here is a comprehensive list of the top 15 international ophthalmology conferences scheduled…

Alcon has announced the U.S. launch of PRECISION7, a groundbreaking contact lens designed for a convenient one-week replacement cycle. Incorporating the advanced 7-day ACTIV-FLO system, these lenses offer up to 16 hours of comfort and clear vision, even on the…

VSY Biotechnology to Complete Global Rollout of its Sinusoidal Vision Technology (SVT®) at ESCRS 2024 This year’s European Society of Cataract and Refractive Surgeons (ESCRS) 2024 kicked off with the highly anticipated third iNovation Day, which brought together the medical…

Alcon announced significant updates to its MARLO App, set to be unveiled at the SECO International meeting in Atlanta. This advanced version of the app, featuring new functionalities, aims to further elevate the patient experience. Patients can now conveniently access…

AMSTERDAM, Oct. 5, 2021 /PRNewswire/ — Within framework of global growth strategy implemented in early 2021, VSY Biotechnology GmbH-Germany and Alsanza Medizintechnik und Pharma GmbH-Germany companies which manufacture and sell their innovative products in ophthalmology and orthopedy fields over 90 countries and 6 continents have decided to…

Sight Sciences announced its success in defeating all four patent invalidity challenges that were filed against it by Alcon and Ivantis in the United States Patent and Trademark Office. Patent Infringement Litigation Over Hydrus® Microstent In September 2021, Sight Sciences…

A recent survey conducted by OBN on LinkedIn asked participants to identify the most pressing challenge facing the ophthalmology field today. The poll revealed that nearly half of the respondents believe patient access to care is the primary issue, followed…

A recent report by Future Market Insights has made some exciting predictions about the therapeutic contact lenses market. The report states that the market is set to experience significant growth in the next decade, rising from an estimated USD 12,595.3…

Micro Labs, based in Bengaluru, announced the launch of Trisopt, the world’s first fixed-dose combination (FDC) to include Brimonidine, Timolol, and Brinzolamide in an ophthalmic suspension, designed specifically for the management of glaucoma. The drug is manufactured within Micro Labs’…

● Download RayPRO on App Store and Google Play.● Listen to Peer2Peer on Spotify, Apple Podcasts, Google Podcasts, and Youtube. Question 1: Can you provide an overview of Rayner’s PayPRO and Peer2Peer platforms?Dr. Stanley Windsor, Digital Innovation Manager: Thank you very much for…